Vemurafenib therapy for stage IV melanoma with V600G-mutation

J Dtsch Dermatol Ges. 2013 Dec;11(12):1198-9. doi: 10.1111/ddg.12200. Epub 2013 Sep 9.

Authors

Nina Lang¹, Andreas Weisser, Alexander Enk, Jessica C Hassel

Affiliation

¹ Department of Dermatology, University of Heidelberg, Heidelberg, Germany.

PMID: 24016000
DOI: 10.1111/ddg.12200

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / therapeutic use
Humans
Indoles / therapeutic use*
Male
Melanoma / drug therapy*
Melanoma / genetics*
Melanoma / pathology
Mutation / genetics*
Neoplasm Staging
Proto-Oncogene Proteins B-raf / genetics*
Skin Neoplasms / drug therapy*
Skin Neoplasms / genetics*
Skin Neoplasms / pathology
Sulfonamides / therapeutic use*
Treatment Outcome
Vemurafenib

Substances

Antineoplastic Agents
Indoles
Sulfonamides
Vemurafenib
BRAF protein, human
Proto-Oncogene Proteins B-raf